Sign in
Stories
Addex Therapeutics to Participate in Bio-Europe 2023 Conference and Release Financial Results
Share
Addex Therapeutics: Financial Updates an...
ADOCIA Files 2023 Registration Document
Addex Therapeutics Enters ADS Offering A...
Addex Therapeutics Meeting
Overview
API
Addex Therapeutics, a clinical-stage pharmaceutical company, will participate in the Bio-Europe 2023 Conference. They will also release their Half-Year 2023 Financial Results on August 10, 2023. Additionally, they have extended their collaboration agreement with Indivior PLC for the discovery of novel oral GABAB positive allosteric modulator (PAM) drug candidates for the treatment of substance use disorder.
Ask a question
How might the extension of the collaboration agreement with Indivior PLC impact Addex Therapeutics' research and development efforts?
What are the key financial results that Addex Therapeutics will be reporting during their Half-Year 2023 Financial Results?
What are the potential implications of Addex Therapeutics' participation in the Bio-Europe 2023 Conference?
Article Frequency
0.2
0.4
0.6
0.8
1.0
May 2023
Jul 2023
Sep 2023
Coverage